Headline News about ARS Pharmaceuticals, Inc. - Common Stock
FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray
September 20, 2023
Via Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 20, 2023
Via Benzinga
Analyst Expectations for ARS Pharmaceuticals's Future
June 21, 2023
Via Benzinga
Via Benzinga
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023
January 31, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
January 04, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
December 13, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|